3.21
price down icon4.46%   -0.15
pre-market  Pre-market:  3.25   0.04   +1.25%
loading
Rocket Pharmaceuticals Inc stock is traded at $3.21, with a volume of 3.38M. It is down -4.46% in the last 24 hours and up +15.88% over the past month. Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
See More
Previous Close:
$3.36
Open:
$3.32
24h Volume:
3.38M
Relative Volume:
0.69
Market Cap:
$342.78M
Revenue:
-
Net Income/Loss:
$-258.08M
P/E Ratio:
-1.1673
EPS:
-2.75
Net Cash Flow:
$-202.32M
1W Performance:
-3.89%
1M Performance:
+15.88%
6M Performance:
-70.03%
1Y Performance:
-87.18%
1-Day Range:
Value
$3.16
$3.33
1-Week Range:
Value
$3.03
$3.42
52-Week Range:
Value
$2.19
$26.98

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name
Name
Rocket Pharmaceuticals Inc
Name
Phone
646-440-9100
Name
Address
350 FIFTH AVENUE, NEW YORK, NY
Name
Employee
299
Name
Twitter
@rocketpharma
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
RCKT's Discussions on Twitter

Compare RCKT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RCKT
Rocket Pharmaceuticals Inc
3.21 362.00M 0 -258.08M -202.32M -2.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

Date Action Analyst Rating Change
May-30-25 Downgrade Evercore ISI Outperform → In-line
May-28-25 Downgrade Goldman Neutral → Sell
May-28-25 Downgrade JP Morgan Overweight → Neutral
May-28-25 Downgrade Jefferies Buy → Hold
May-28-25 Downgrade Leerink Partners Outperform → Market Perform
May-28-25 Downgrade Morgan Stanley Overweight → Equal-Weight
May-27-25 Downgrade Needham Buy → Hold
May-27-25 Downgrade TD Cowen Buy → Hold
Mar-12-25 Initiated BMO Capital Markets Outperform
Dec-30-24 Initiated Wedbush Outperform
Dec-18-24 Initiated Jefferies Buy
Oct-16-24 Initiated Scotiabank Sector Outperform
Apr-02-24 Initiated Goldman Neutral
Oct-24-23 Initiated Cantor Fitzgerald Overweight
Feb-01-23 Initiated Morgan Stanley Overweight
Nov-08-22 Initiated Canaccord Genuity Buy
Nov-01-22 Initiated BTIG Research Buy
Jul-08-22 Initiated Raymond James Outperform
Oct-20-21 Resumed Cowen Outperform
Mar-02-21 Initiated Stifel Buy
Feb-18-21 Initiated Needham Buy
Dec-16-20 Initiated UBS Buy
Dec-08-20 Downgrade Oppenheimer Outperform → Perform
Jul-02-20 Initiated JP Morgan Overweight
Jun-25-20 Resumed BofA/Merrill Buy
Jun-01-20 Resumed Oppenheimer Outperform
Nov-06-19 Initiated Chardan Capital Markets Buy
Sep-26-19 Initiated Piper Jaffray Overweight
Apr-23-19 Initiated Robert W. Baird Outperform
Mar-15-19 Initiated BofA/Merrill Buy
Feb-05-19 Initiated Oppenheimer Outperform
Sep-13-18 Initiated Ladenburg Thalmann Buy
Jul-10-18 Initiated William Blair Outperform
View All

Rocket Pharmaceuticals Inc Stock (RCKT) Latest News

pulisher
02:14 AM

Rocket Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastFree Predictions - PrintWeekIndia

02:14 AM
pulisher
Jul 24, 2025

Rocket Pharmaceuticals Inc. Stock Analysis and ForecastHigh-octane financial growth - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

Levi & Korsinsky Urges Rocket Pharmaceuticals, Inc. (RCKT) Shareholders to Act Before Lead Plaintiff Deadline August 11, 2025 - Barchart.com

Jul 24, 2025
pulisher
Jul 24, 2025

Investor Alert: Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Trial Safety Concerns - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Rocket Pharmaceuticals Inc. Equity Warrant stockAccelerated investment success - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals to cut 30% of workforce - NJBIZ

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharma falls on delay of certain drug development programs - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals (RCKT) Restructures, Cuts Workforce by 30% - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals cuts headcount, realigns pipeline - Seeking Alpha

Jul 24, 2025
pulisher
Jul 24, 2025

The Fragile Equilibrium: Assessing Rocket Pharmaceuticals Amid Securities Litigation and Governance Concerns - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

RCKT LAWSUIT ALERT: The Gross Law Firm Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals (RCKT) Restructures for Strategic Focus a - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals Announces Strategic Reorganization - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals cuts workforce by 30% to focus on heart therapies - Investing.com Australia

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals Announces Strategic Corporate Reorganizat - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs - Business Wire

Jul 24, 2025
pulisher
Jul 23, 2025

FDA Clinical Hold on RP-A501 Trial Triggers Rocket - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Rocket Pharmaceuticals Announces Strategic Reorganization Plan - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025Contact Levi & Korsinsky - Barchart.com

Jul 23, 2025
pulisher
Jul 23, 2025

Investor Alert: Securities Class Action Filed Against Rocket Pharmaceuticals (RCKT) - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

RCKT Class Action Reminder: Robbins LLP Reminds Rocket Pharmaceuticals, Inc. Investors of the Class Action LawsuitContact us for more information - PR Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

RCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - PR Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - PR Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

Signaturefd LLC Increases Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - StreetInsider

Jul 22, 2025
pulisher
Jul 22, 2025

Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. (RCKT) Shareholders of Class Action Lawsuit and August 11, 2025 Deadline - Barchart.com

Jul 22, 2025
pulisher
Jul 22, 2025

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class ActionHagens Berman - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Rocket Pharmaceuticals Inc. Equity Warrant stock priceTremendous growth potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) SHAREHOLDER - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Rocket Pharmaceuticals Inc (RCKT) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT)August 11, 2025 Deadline to JoinContact The Gross Law Firm - PR Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Jul 21, 2025
pulisher
Jul 20, 2025

Is Rocket Pharmaceuticals Inc. a good long term investmentAccelerated capital growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky to Join Class Action Before August 11, 2025 - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 20, 2025

2025-07-20 | Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky to Join Class Action Before August 11, 2025 | NDAQ:RCKT | Press Release - Stockhouse

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Rocket Pharmaceuticals Inc. stockRapid-fire capital growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Jul 20, 2025
pulisher
Jul 20, 2025

2025-07-20 | RCKT LAWSUIT ALERT: Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. InvestorsLead Plaintiff Deadline August 11, 2025 | NDAQ:RCKT | Press Release - Stockhouse

Jul 20, 2025
pulisher
Jul 19, 2025

2025-07-19 | RCKT ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Rocket Pharmaceuticals, Inc.August 11, 2025 Deadline | NDAQ:RCKT | Press Release - Stockhouse

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Rocket Pharmaceuticals Inc. stock priceHigh-profit trading signals - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Rocket - GlobeNewswire

Jul 19, 2025
pulisher
Jul 18, 2025

Is Rocket Pharmaceuticals Inc. Equity Warrant a good long term investmentUnrivaled growth potential - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

2025-07-18 | Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025Contact Levi & Korsinsky | NDAQ:RCKT | Press Release - Stockhouse

Jul 18, 2025

Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Cap:     |  Volume (24h):